Total Funding
63
3
Total FundingVenture - Series Unknown raised
Growth Score 63 in past quarter
-3 pts
Heat Score 3 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
886092
Enobia Pharma develops therapies for the treatment of serious genetic bone disorders.
Acquired by 
Alexion Pharmaceuticals
- Clare Carmichael: Senior Vice President, Chief Human Resources OfficerPast Role: Watson Pharmaceuticals, SVP Global Human Resources
Frank Wright: Senior Vice PresidentPast Role: Aptuit LLC, Co-Founder & Vice Chairman
About the Company
Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments.


